# Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma

> **NCT01716208** · PHASE2 · COMPLETED · sponsor: **Joseph Tuscano** · enrollment: 12 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Ofatumumab + Fresh Frozen Plasma

## Key facts

- **NCT ID:** NCT01716208
- **Lead sponsor:** Joseph Tuscano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-14
- **Primary completion:** 2019-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716208, "Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01716208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*